Doré Copper Mining to Present at Alpha Bronze Virtual Town Hall
NEW YORK, NY / ACCESSWIRE / April 13, 2021 / Alpha Bronze, LLC ( Alpha Bronze ), is pleased to announce that Doré Copper Mining (TSXV:DCMC)(OTCQB:DRCMF) ( Doré Copper or the Company ), a copper-gold explorer and developer in the Chibougamau area of Québec, will be presenting at Alpha Bronze Virtual Town Hall on Wednesday, April 14, 2021 at 12:00 PM ET.
Mr. Ernest Mast, Chief Executive Officer of Doré Copper will give an overview of the Company, its hub-and-spoke development strategy built on advancing its high-grade copper-gold brownfield projects towards a restart of operations. Mr. Mast will respond to Investors questions thereafter.
Dore Copper Mining to Present at Alpha Bronze Virtual Town Hall
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Dore Copper Mining to Present at Alpha Bronze Virtual Town Hall
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Helix BioPharma Corp Extends Period to Exercise Warrants
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Helix BioPharma Corp. Announces Fiscal Second Quarter 2021 Results
March 16, 2021 GMT
RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX: HBP ), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second .
RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX: HBP ), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second .
RICHMOND HILL, ON / ACCESSWIRE / March 16, 2021 / Helix BioPharma Corp. (TSX:“HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal second quarter ended January 31, 2021.